36
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Antineoplastic activity and toxicity of some alkylating cytostatics (Cyclophosphamide, CCNU, Cytostasan) encapsulated in liposomes in different murine tumour models

, &
Pages 77-87 | Received 08 Jan 1986, Accepted 07 Feb 1986, Published online: 27 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Marco Montillo, Francesca Ricci, Alessandra Tedeschi, Eleonora Vismara & Enrica Morra. (2010) Bendamustine: new perspective for an old drug in lymphoproliferative disorders. Expert Review of Hematology 3:2, pages 131-148.
Read now
M. Van Borssum Waalkes, I. Fichtner, B. Dontje, M. Lemm, M. Becker, D. Arndt & G. L. Scherphof. (1992) In vivo distribution and antitumour activity of liposomal 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine. Journal of Microencapsulation 9:3, pages 335-346.
Read now

Articles from other publishers (3)

Shoko Goto, Hiroaki Goto & Tomoko Yokosuka. (2016) The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells. International Journal of Hematology 103:5, pages 572-583.
Crossref
Sayed S. Daoud, Lisbeth R. Hume & R.L. Juliano. (1989) Liposomes in cancer therapy. Advanced Drug Delivery Reviews 3:3, pages 405-418.
Crossref
Akeo Hagiwara, Toshio Takahashi, Naoto Oku & Shigeru Tsukagoshi. (1989) Cancer chemotherapy administered by activated carbon particles and liposomes. Critical Reviews in Oncology/Hematology 9:4, pages 319-350.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.